H. Gunthard et A. Pennekamp, CLINICAL-SIGNIFICANCE OF EXTRAINTESTINAL HAFNIA-ALVEI ISOLATES FROM 61 PATIENTS AND REVIEW OF THE LITERATURE, Clinical infectious diseases, 22(6), 1996, pp. 1040-1045
Hafnia alvei is a gram-negative bacterium that is rarely isolated from
human specimens and is rarely considered to be pathogenic. It has bee
n associated with gastroenteritis, meningitis, bacteremia, pneumonia,
nosocomial wound infections, endophthalmitis, and a buttock abscess. W
e studied 80 H. alvei isolates recovered from 61 patients within a per
iod of 30 months. H. alvei was cultured from sites that included the r
espiratory tract (n = 38), the gastrointestinal tract (n = 16), and th
e urogenital tract (n = 12); the organism was found in blood cultures
(n = 8), on central venous catheters (n = 3), and on the skin (n = 3).
Only 25% of H. alvei isolates were recovered in pure cultures. Fifty-
seven (93.4%) of the patients had an underlying illness, H. alvei prov
ed to be the etiologic agent in two episodes of septicemia and in one
episode of peritonitis and was probably responsible for septicemia in
two other patients and pneumonia in one. All six of these patients rec
overed after receiving antibiotic treatment and/or standard surgical t
reatment, when needed. Three of these infections were nosocomial, and
three were community acquired. Of the strains of H. alvei tested in ou
r study, 100% were susceptible to netilmicin, ciprofloxacin, and imipe
nem; 92% were susceptible to piperacillin; 90% were susceptible to co-
trimoxazole; and 88% were susceptible to ceftriaxone and ceftazidime.
In this study, we found H. alvei to be a rare but significant etiologi
c agent of nosocomial and community-acquired infections.